ID   WAe009-A-45
AC   CVCL_A1MY
SY   TBX5-KO; GOAHe010-A-45
DR   BioSamples; SAMEA8072991
DR   hPSCreg; WAe009-A-45
DR   Wikidata; Q102115104
RX   PubMed=33497883;
CC   From: Gynaecology and Obstetrics, Anzhen Hospital; Beijing; China.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; 11604; TBX5.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
ST   Source(s): hPSCreg
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 9
ST   D16S539: 12,13
ST   D21S11: 30
ST   D5S818: 11,12
ST   D7S820: 9,11
ST   TH01: 9.3
ST   TPOX: 10,11
ST   vWA: 17
DI   NCIt; C125592; Holt-Oram syndrome
DI   ORDO; Orphanet_392; Holt-Oram syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9773 ! WA09
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 29-10-20; Last updated: 29-06-23; Version: 5
//
RX   PubMed=33497883; DOI=10.1016/j.scr.2021.102156;
RA   Zhao T.-T., Bai R., Wu F.-J., Lu W.-J., Zhang J.;
RT   "Generation of a TBX5 homozygous knockout embryonic stem cell line
RT   (WAe009-A-45) by CRISPR/Cas9 genome editing.";
RL   Stem Cell Res. 51:102156-102156(2021).
//